Will Behçet's Disease Burn Out With Age?
At a Glance
Behçet's disease symptoms, such as mouth sores and rashes, often "burn out" or become less severe as patients enter their 40s and 50s. However, ongoing monitoring by a rheumatologist is still essential to catch silent, long-term complications involving the blood vessels, eyes, and nervous system.
In this answer
2 sections
Yes, it is common for Behçet’s disease to eventually “burn out” or become less severe as you get older [1][2]. For many people, the disease activity gradually decreases in both frequency and intensity as they reach middle age [3][4]. However, while your everyday flares—such as mouth sores, skin rashes, and joint pain—may calm down over time, it is crucial to continue monitoring your health, as the risk for complications involving your blood vessels, eyes, or nervous system can remain [5][6][7].
Understanding the “Burn Out” Phenomenon
Behçet’s disease typically follows a relapsing-remitting course, meaning you have periods of active symptoms (flares) followed by periods where you feel relatively well (remission) [3]. As the years pass, especially as patients enter their 40s and 50s, many notice that the severity of these flares begins to fade [1].
- What often improves: The most common day-to-day symptoms, known as mucocutaneous symptoms (like mouth ulcers, genital sores, and skin rashes), are the most likely to decrease in frequency and severity as you age [5].
- Not a guarantee: It is important to know that this “burn out” effect is not guaranteed for everyone, and there are currently no reliable blood tests or markers that can predict exactly when or if your disease will calm down [7][1].
Why Ongoing Monitoring is Essential
Even if you feel like your disease has “burned out” and your skin or mouth symptoms have stopped, you still need regular check-ups coordinated by your rheumatologist or specialized care team [8]. Behçet’s disease is a type of vasculitis, meaning it causes inflammation of the blood vessels, which can cause silent damage over time [9].
While severe new symptoms involving the eyes or nervous system typically appear in the first decade after diagnosis, you and your healthcare team must continue to watch for late-onset risks and cumulative damage [10][11][12]:
- Vascular issues: Inflammation can weaken blood vessels, leading to aneurysms (bulging of a blood vessel wall) or thrombosis (blood clots), even during periods when you feel well [13][8].
- Eye health: Severe eye inflammation, particularly uveitis (inflammation inside the eye), can lead to long-term vision problems and requires continued evaluation by an eye specialist [14][15].
- Nervous system: Neurological involvement (neuro-Behçet’s) can still cause ongoing issues or relapses that require vigilance [14].
- Heart health: Prolonged blood vessel inflammation can sometimes lead to early heart issues, such as problems with how the heart relaxes between beats or inflammation of the heart’s structures [16].
How Your Care Team Will Monitor You
To catch any silent internal changes early, your doctors may use specific tests rather than just waiting for symptoms to appear. This often includes advanced imaging like PET/CT scans to look for hidden inflammation in your blood vessels, or echocardiograms to check your heart health [8][17]. Regular monitoring allows your medical team to protect your long-term health and ensure that your later years remain as healthy and comfortable as possible.
Common questions in this guide
Does Behçet's disease ever go away completely?
Why do I need to keep seeing a doctor if my Behçet's symptoms have stopped?
What tests are used to monitor Behçet's disease during remission?
Can I stop taking my medications if my Behçet's disease burns out?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Are there specific baseline scans or imaging, like an echocardiogram or PET/CT scan, that we should do to check my blood vessels and organs?
- 2.Which specific symptoms should prompt me to call your office immediately, rather than waiting for my next scheduled check-up?
- 3.Since my risk profile might change as I age, how often do I need to see my eye doctor and rheumatologist for routine monitoring?
- 4.If my daily flares (like mouth sores) start to decrease, what steps do we take to safely reduce my current medications?
- 5.How do we distinguish between normal age-related health changes and 'silent' internal damage caused by Behçet's disease?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
Behçet's disease unraveled: Insights into clinical manifestations, diagnosis, and management.
Alghamdi M, Lindsey S
Medicine 2025; (104(49)):e44614 doi:10.1097/MD.0000000000044614.
PMID: 41367023 - 2
New and future perspectives in Behçet's syndrome.
Sulu B, Hatemi G
Archives of rheumatology 2024; (39(4)):511-521 doi:10.46497/ArchRheumatol.2024.11049.
PMID: 40060132 - 3
Oral Health and Its Aetiological Role in Behçet's Disease.
Mumcu G, Fortune F
Frontiers in medicine 2021; (8()):613419 doi:10.3389/fmed.2021.613419.
PMID: 34095159 - 4
Mucocutaneous manifestations of Behçet's disease: Pathogenesis and management from perspectives of vasculitis.
Kim D, Nakamura K, Kaneko F, et al.
Frontiers in medicine 2022; (9()):987393 doi:10.3389/fmed.2022.987393.
PMID: 36530905 - 5
Abnormal glucose and lipid metabolism promotes disrupted differentiation of T and B cell subsets in Behçet's disease.
Li M, Li P, Wang X, et al.
Immunotherapy advances 2025; (5(1)):ltaf010 doi:10.1093/immadv/ltaf010.
PMID: 40297266 - 6
Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet's disease: A systematic review and meta-analysis.
Iizuka Y, Takase-Minegishi K, Hirahara L, et al.
Modern rheumatology 2022; (32(6)):1153-1162 doi:10.1093/mr/roab098.
PMID: 34752620 - 7
International consensuses and guidelines on managing ocular Behçet's disease by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-Retina Society (APVRS), the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII) and the Academia Retina Internationalis (ARI).
Chan VTT, Mak ACY, Agrawal R, et al.
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2025; (14(6)):100261 doi:10.1016/j.apjo.2025.100261.
PMID: 41207387 - 8
Pulmonary artery thrombosis as the first presentation of Behçet's syndrome: a case report and review of the literature.
Alakkas Z, Kazi W, Mattar M, et al.
Journal of medical case reports 2021; (15(1)):322 doi:10.1186/s13256-021-02931-1.
PMID: 34154640 - 9
Behcet's disease.
Nair JR, Moots RJ
Clinical medicine (London, England) 2017; (17(1)):71-77 doi:10.7861/clinmedicine.17-1-71.
PMID: 28148585 - 10
Behçet's disease: How to diagnose and treat vascular involvement.
Seyahi E
Best practice & research. Clinical rheumatology 2016; (30(2)):279-295 doi:10.1016/j.berh.2016.08.002.
PMID: 27886800 - 11
Relationship between age at onset and clinical characteristics of Behçet's disease.
Ghembaza MEA, Lounici A
Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2018; (27(4)):175-177.
PMID: 30564829 - 12
Cutaneous and Extracutaneous Manifestations of Behçet's Disease Linked to Its Disease Activity and Prognosis.
Limtong P, Chanprapaph K, Vachiramon V, Ngamjanyaporn P
Clinical, cosmetic and investigational dermatology 2020; (13()):639-647 doi:10.2147/CCID.S265169.
PMID: 32904702 - 13
Vasculo-Behçet's disease with a giant pseudoaneurysm of superficial femoral artery: A case report.
Al-Doud MA, Al-Nusairat AN, Al-Shanableh NM, et al.
International journal of surgery case reports 2023; (109()):108534 doi:10.1016/j.ijscr.2023.108534.
PMID: 37524014 - 14
Neuro-Behçet's disease mimicking a cranial tumour.
Senol S, Ucar M, İmamoğlu H, Yildirim A
BMJ case reports 2015; (2015()).
PMID: 26101297 - 15
Behçet syndrome: a contemporary view.
Yazici H, Seyahi E, Hatemi G, Yazici Y
Nature reviews. Rheumatology 2018; (14(2)):107-119 doi:10.1038/nrrheum.2017.208.
PMID: 29296024 - 16
Diastolic dysfunction in Behçet's disease and its relationship with clinical manifestations of the disease: A case-control study.
Varkal G, Eker Akıllı R, Türk İ, et al.
Archives of rheumatology 2024; (39(4)):624-630 doi:10.46497/ArchRheumatol.2024.10772.
PMID: 40060119 - 17
Vasculo-Behçet disease complicated by conversion disorder diagnosed with 18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography (PET/CT).
Furuya MY, Temmoku J, Fujita Y, et al.
Fukushima journal of medical science 2019; (65(2)):55-60 doi:10.5387/fms.2019-07.
PMID: 31327803
This information is for educational purposes and does not replace professional medical advice. Always consult your rheumatologist or specialized care team regarding changes in your Behçet's disease symptoms and monitoring plan.
Get notified when new evidence is published on Behçet disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.